Since NLRP3−/− and caspase-1−/− animal models have confirmed enhanced amyloid β clearance and protection from the loss of spatial memory [97], blocking of NLRP3 activation and the NLRP3 inflammasome derived cytokines might be a new therapeutic intervention for AD. The gene discussed is NLRP3; the disease is Alzheimer disease.